Diazepam Sugar Free Accord-Uk (Diazepam)

Diazepam Sugar Free Accord-Uk is prescribed for several neurological and psychiatric conditions where modulation of GABA‑A activity is beneficial.

• Management of generalized anxiety disorder and acute anxiety episodes.
• Adjunct therapy for various seizure disorders, including status epilepticus.
• Relief of muscle spasm associated with musculoskeletal conditions.
• Treatment of alcohol withdrawal symptoms.
• Short‑term sedation before medical procedures.

Side‑effect profiles for diazepam include both frequently observed reactions and less common but potentially serious events.

Common

• Drowsiness or fatigue.
• Light‑headedness or dizziness.
• Impaired coordination or balance.
• Blurred vision.
• Dry mouth.
• Mild gastrointestinal upset.

Serious

• Severe respiratory depression.
• Marked hypotension.
• Paradoxical agitation or aggression.
• Hepatic dysfunction or jaundice.
• Dependence, withdrawal syndrome, or tolerance.
• Allergic reactions such as rash, swelling, or anaphylaxis.

When considering diazepam therapy, clinicians and patients should be aware of several safety considerations.

• Assess for a history of respiratory disease, liver impairment, or renal insufficiency.
• Use the lowest effective dose for the shortest duration to limit dependence risk.
• Avoid abrupt discontinuation after prolonged use to prevent withdrawal seizures.
• Caution in elderly patients due to increased fall risk and cognitive effects.
• Discuss potential sedation with activities requiring alertness, such as driving.
• Evaluate pregnancy and breastfeeding status, as safety data are limited.

Diazepam can interact with a range of other medicines, influencing its efficacy or safety.

Avoid

• Concurrent use with other central nervous system depressants (e.g., opioids, barbiturates, alcohol).
• Strong CYP3A4 inhibitors such as ketoconazole, itraconazole, or clarithromycin.
• Medications that prolong the QT interval.

Use with caution

• Other benzodiazepines or sedative‑hypnotics.
• Antidepressants that affect serotonin levels (e.g., SSRIs, SNRIs).
• Anticonvulsants that may alter seizure threshold.
• Drugs that are highly protein‑bound, potentially displacing diazepam.